Ispire Technology Inc. Reports Strong Financial Developments
Cash of $17.6 Million at December 31, 2025 | Significant Reduction of Net Accounts Receivable
LOS ANGELES – Ispire Technology Inc. (NASDAQ: ISPR), a pioneering company in vaping technology and precision dosing, recently detailed its financial outcomes for the second quarter of fiscal 2026. This report covers the three months concluded on December 31, 2025.
Fiscal Second Quarter 2026 Financial Highlights
Revenue: $20.3 million compared to $41.8 million in the same period last year.
Gross Profit: $3.5 million, down from $7.7 million year over year.
Gross Margin: 17.1%, slightly down from 18.5% in the second quarter of fiscal 2025.
Total Operating Expenses: Reduced to $10.3 million from $15.1 million in the previous year.
Net Loss: $6.6 million, an improvement compared to $8.0 million loss for the same quarter last year.
Strategic Focus and Commentaries from Leadership
Michael Wang, Co-Chief Executive Officer of Ispire, remarked, "This quarter marks a crucial turning point as we embark on a year-long journey focused on cost management and optimizing customer quality. We are optimistic that upcoming quarters will yield growth in revenues, consistent cash inflows, and overall financial improvements. Our commitment to high-quality revenue remains unwavering, and the noteworthy 19.5% reduction in net accounts receivable to $37.9 million is a testament to this focus.”
Our advancements in manufacturing capabilities in Malaysia are set to enhance production throughout this fiscal year. The interest around our proprietary G-Mesh technology is growing, with several major nicotine manufacturers actively exploring its use in next-gen vaping devices, which we believe will pave the way for valuable licensing and partnership opportunities.
Enhancements in Operating Expenses and Financial Position
Chief Financial Officer Jay Yu emphasized ongoing progress in strengthening Ispire’s financial infrastructure, stating, "Our disciplined cost management contributed to a marked decline in operating expenses, improving our net accounts receivable to $37.9 million by the end of December 2025. This approach enhances the Company’s financial flexibility and lays the groundwork for sustained value creation in the future.”
The strategic pivot away from lower-quality cannabis customers has impacted overall product sales and consequently revenue. Yet, this transition has been essential for aligning with high-quality business operations.
Operational Developments and Future Prospects
Looking ahead, Ispire envisions continued enhancement within the industry. Our joint venture with IKE Tech is gaining momentum, collaborating with regulators globally to promote the adoption of age-gating technology, which is increasingly recognized as a necessary measure to ensure safer standards within the industry. In addition, our focus on differentiating our products and incorporating advanced technology ensures we remain at the forefront of regulatory compliance and market demand.
In the United States, consumer interest in flavored e-cigarettes persists. However, it’s notable that many of these products are unauthorized by the FDA and primarily distributed through illicit channels. We are committed to supporting successful enforcement measures that work alongside the establishment of a robust legal market for FDA-approved flavored products.
Upcoming Conference Call Details
The Company is hosting a conference call on Friday, February 6, 2026, at 8:00 am ET to discuss these financial results. During this call, executives will delve into insights from the quarter and provide responses to participant questions. Interested parties can dial in using the contact numbers provided, and access the recorded playback until noted dates.
More detailed financial data and reports will be accessible during the conference call, which will also be both live-streamed and recorded for reference.
About Ispire Technology Inc.
Ispire specializes in research and development, designing, marketing, and distributing a wide range of e-cigarettes and cannabis vaping products. The company holds ownership or licensing rights to over 400 patents globally. Ispire’s products, marketed under the Aspire brand, are available worldwide (excluding specific regions), leveraging a global distribution network for maximum outreach.
With an expanding footprint into new markets like Canada and Latin America, Ispire is set to continue its innovation trajectory.
Frequently Asked Questions
What significant financial changes did Ispire Technology Inc. report?
Ispire reported a revenue decline to $20.3 million from $41.8 million compared to the same period last year, while reducing operating expenses to $10.3 million.
How has Ispire reduced its net accounts receivable?
Ispire achieved a reduction of 19.5% in net accounts receivable, reflecting a strategic focus on acquiring higher-quality customers.
What technologies is Ispire focusing on for the future?
Ispire is investing in G-Mesh technology for next-gen vaping devices and implementing age-gating technology through its IKE Tech joint venture.
How is Ispire addressing the U.S. flavored e-cigarette market?
Ispire is focused on creating a legal market for flavored e-cigarettes while collaborating with regulators against illicit trade.
When will Ispire conduct its next earnings conference call?
The next earnings call is scheduled for February 6, 2026, at 8:00 am ET, where they will elaborate on financial results.
